Bellevue Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bellevue Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-266,226	Closed	-$34.5M	–	170
2023 Q3	$34.5M	Sell	266,226 -22,553	-8%	-$2.92M	0.56%	50
2023 Q2	$35.8M	Sell	288,779 -281,078	-49%	-$34.8M	0.51%	61
2023 Q1	$83.4M	Sell	569,857 -186,779	-25%	-$27.3M	1.21%	26
2022 Q4	$121M	Sell	756,636 -67,203	-8%	-$10.7M	1.6%	13
2022 Q3	$110M	Sell	823,839 -94,068	-10%	-$12.5M	1.58%	16
2022 Q2	$143M	Buy	917,907 +162,926	+22%	+$25.4M	2.02%	13
2022 Q1	$118M	Sell	754,981 -131,873	-15%	-$20.5M	1.36%	21
2021 Q4	$113M	Buy	886,854 +117,616	+15%	+$15M	1.16%	27
2021 Q3	$100M	Buy	769,238 +224,488	+41%	+$29.2M	1.02%	32
2021 Q2	$96.8M	Sell	544,750 -5,900	-1%	-$1.05M	0.94%	33
2021 Q1	$90.5M	Buy	550,650 +161,785	+42%	+$26.6M	0.96%	33
2020 Q4	$64.2M	Buy	388,865 +32,515	+9%	+$5.37M	0.74%	40
2020 Q3	$50.8M	Buy	356,350 +65,214	+22%	+$9.3M	0.7%	42
2020 Q2	$32.1M	Sell	291,136 -80,201	-22%	-$8.85M	0.45%	56
2020 Q1	$37M	Sell	371,337 -9,966	-3%	-$994K	0.72%	38
2019 Q4	$56.9M	Buy	381,303 +51,076	+15%	+$7.62M	0.9%	34
2019 Q3	$42.3M	Sell	330,227 -1,946	-0.6%	-$249K	0.79%	37
2019 Q2	$47.4M	Buy	332,173 +64,735	+24%	+$9.23M	0.81%	36
2019 Q1	$38.2M	Buy	267,438 +6,790	+3%	+$971K	2.1%	11
2018 Q4	$32.3M	Buy	260,648 +46,890	+22%	+$5.81M	2.12%	12
2018 Q3	$35.9M	Buy	213,758 +48,825	+30%	+$8.21M	2.28%	11
2018 Q2	$28.4M	Buy	164,933 +13,211	+9%	+$2.28M	2.42%	10
2018 Q1	$22.9M	Sell	151,722 -3,860	-2%	-$583K	2.27%	11
2017 Q4	$20.9M	Buy	155,582 +40,330	+35%	+$5.43M	2.19%	11
2017 Q3	$16.9M	Buy	115,252 +15,049	+15%	+$2.2M	1.76%	17
2017 Q2	$15.6M	Sell	100,203 -6,397	-6%	-$995K	1.84%	14
2017 Q1	$15.5M	Buy	106,600 +22,800	+27%	+$3.31M	2.06%	14
2016 Q4	$9.14M	Hold	83,800	–	–	1.87%	17
2016 Q3	$10.2M	Buy	83,800 +8,500	+11%	+$1.03M	1.84%	15
2016 Q2	$10.6M	Buy	75,300 +12,800	+20%	+$1.81M	2%	13
2016 Q1	$8.16M	Buy	+62,500	New	+$8.16M	1.48%	19